MedPath

IBRANCE 100 MG CAPSULAS DURAS

IBRANCE 100 MG CAPSULAS DURAS

Commercialized
Register Number

1161147003

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Dec 23, 2016

Dosage Form

CÁPSULA DURA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1161147003
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

PALBOCICLIBActive
Quantity: 100 mg
Name: PALBOCICLIB

ATC CLASSIFICATION (3)

L01E
L01EF
L01EF01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.